Safety assessment of β-nitropropionic acid: A monograph in support of an acceptable daily intake in humans

Food Chemistry

Volumn 75, Issue 1, 2001, Pages 1-27

  Burdock, George A ^a   Carabin, Ioana G ^a   Soni, Madhusudan G ^a  

^a Burdock and Associates Inc   (United States)

Author keywords

Excitotoxicity; Huntington's disease; Mitochondrial toxin; NPA

Indexed keywords

3 NITROPROPIONIC ACID; SUCCINATE DEHYDROGENASE;

ANIMAL EXPERIMENT; BIOSYNTHESIS; CARCINOGEN TESTING; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; CYTOTOXICITY; DRUG ACTIVITY; DRUG DEGRADATION; DRUG METABOLISM; DRUG SAFETY; FOOD; FUNGUS; GAS CHROMATOGRAPHY; GENOTOXICITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUNTINGTON CHOREA; MOUSE; MUTAGENICITY; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; RAT; REVIEW; THIN LAYER CHROMATOGRAPHY; TOXICITY TESTING; TOXICOKINETICS;

EID: 0034866259     PISSN: 03088146     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0308-8146(01)00194-7     Document Type: Review

References (139)

1. Variable susceptibility to neurotoxicity of systemic 3-nitropropionic acid
2. 3-Nitropropionic acid's lethal triplet: cooperative pathways of neurodegeneration
3. Suicide substrates for mitochondrial enzymes
4. 3-Nitropropionate, the toxic substance of Indigofera, is a suicide inactivator of succinate dehydrogenase
5. The bioorganic chemistry of the nitroalkyl group
6. Metabolism of the plant toxins nitropropionic acid and nitropropanol by ruminal microorganisms
7. Indigofera spp. with agronomic potential in the tropics rat toxicity studies
8. Genotoxicity testing of five compounds in three Drosophila short-term somatic assays
9. Fungal biosynthesis of 3-nitropropanoic acid
10. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid
11. Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate
12. 3-Nitropropionic acid neurotoxicity is attenuated in copper/Zinc superoxide dismutase transgenic mice
13. Effect of glucose on the oxidation of beta-nitropropionic acid by Aspergillus flavus
14. Toxicology of karaka kernel, karakin, and beta-nitropropionic acid
15. In vitro biotransformation of 3-nitropropanol (misertoxin aglycone) by horse liver alcohol dehydrogenase
16. Increase in levels of total free fatty acids in rat brain regions following 3-nitropropionic acid administration
17. Effect of acute exposure to 3-nitropropionic acid on activities of endogenous antioxidants in the rat brains
18. Hyperactivity and hypoactivity in a rat model of Huntington's disease: the systemic 3-nitropropionic acid model
19. Age dependence on striatal neuronal death caused by mitochondrial dysfunction
20. Chronic administration of 3-nitropropionic acid induced selective striatal degeneration and abnormal choreiform movements in monkeys
21. Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movement in primates
22. Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid
23. Biosynthesis of 3-nitropropionic acid in creeping indigo (Indigofera spicata)
24. The constitution of karakin
25. Hiptagenic acid identified as β-nitropropionic acid
26. Evaluation of the L5178Y mouse lymphoma cell mutagenesis assay: interlaboratory reproducibility and assessment
27. The mutagenic activity of selected compounds at the TK locus: rodent vs. human cells
28. Analysis of the cardiodepressor action of 3-nitropropionic acid
29. An analysis of the antihypertensive properties of 3-nitropropionic acid, a compound from plants in the genus Astragalus
30. Inactivation of succinate dehydrogeanse by 3-nitropropionate
31. The toxic constituent of Indigofera endecaphylla
32. Early N-acetylaspartate depletion is a marker of neuronal dysfunction in rats and primates chronically treated with the mitochondrial toxin 3-nitropropionic acid
33. In vitro protection of 3-nitropropionic acid-induced toxicity of astrocytes by basic fibroblast growth factor and thrombin
34. Alterations of gamma-amino butyric acid metabolism in brain by 3-nitro propionic acid
35. Mutagenic activity of chemicals previously tested for carcinogenicity in the National Cancer Institite Bioassay Program
36. Nitro compounds in Astragalus species from Iran
37. Effects of 3-nitropropionic acid on synaptosmoal energy and transmitter metabolism: relevance to neurodegenerative brain diseases
38. Identification and phytotoxicity of 3-nitropropanoic acid produced in vitro by Melanconis thelebola
39. Beta nitropropionic acid concentration of crownvetch plant parts as affected by growth-temperature-maturation variables
40. Striatal pathology of impaired mitochondrial metabolism in primates profiles Huntington's disease
41. Standardized high performance liquid chromatography of 182 mycotoxins and other fungal metabolites based on alkylphenone retention indexes and UV-VIS spectra (diode array detection)
42. Lipid peroxidation in rats intoxicated with 3-nitropropionic acid
43. Astrocytes are more vulnerable than neurons to cellular Ca2+ overload induced by a mitochondrial toxin, 3-nitropropionic acid
44. Electron affinity gas chromatographic determination of beta-nitropropionic acid as its pentafluorobenzyl derivative in cheeses and mold filtrates
45. Studies on the distribution of a naturally occurring nitroaliphatic acid in crown vetch (Coronilla varia, Fabaceae)
46. Basal ganglia degeneration, myelin alteration and enzyme inhibition induced in mice by the plant toxin 3-nitropropionic acid
47. Brain enzyme and clinical alterations induced in rats and mice by nitroaliphatic toxicants
48. Isolation and some properties of an enzyme system which catalyzes the degradation of beta-nitropropionic acid
49. Aliphatic nitro compounds in crownvetch: a review
50. Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid
51. Nature and distribution of brain lesions in rats intoxicated with 3-nitropropionic acid: a type of hypoxic (energy deficient) brain damage
52. Correlation of morpholgic brain lesions with physiologic alterations and blood brain barrier impairment in 3-nitropropionic acid toxicity in rats
53. History of 3-nitropropionic acid: Occurrence and role in human and animal disease
54. Enzyme and structural alterations in brains of rats intoxicated with 3-nitropropionic acid
55. Ames mutagenicity tests on purified 3-nitropropionic acid
56. Tumor incidences in Fischer 344 rats: NTP historical data
57. Septoria cirsii, a potential biocontrol agent of Canada thistle and its phytotoxin- β-nitropropionic acid
58. Vasodilator and antihypertensive actions of 3-nitropropionic acid
59. Studies on the toxicity of Indigofera endecaphylla. I. Toxicity for rabbits
60. Production of β-nitropropionic acid in foods
61. Field and experimental studies in cattle and sheep poisoned by nitro-bearing Astragalus or their toxins
62. Dopamine toxicity following long term exposure to low doses of 3-nitropropionic acid (3-NPA) in rats
63. Toxic metabolites of an unidentified filamentous fungus isolated from Zinnia leaves
64. Mycotoxins in fermented food
65. Excitotoxicity is required for induction of oxidative stress and apoptosis in mouse striatum by mitochondrial toxin, 3-nitropropionic acid
66. Predicting rodent carcinogenicity of Ames test false positives by in vivo biochemical parameters
67. Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic caid, and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine
68. An observation on the regularity of mould invasion into sugarcane and its prevention
69. Anthrinium spp. and the etiology of deteriorted sugarcane poisoning
70. Studies on the epidemiology and etiology of moldy sugarcane poisoning in China
71. Characterization of 3-nitropropionic acid-induced bradycardia in isolated atria
72. 3-Nitropropionic acid- exogenous animal neurotoxin and possible human striatal toxin
73. 3-Nitropropionic acid decreases cellular energy levels and causes neuronal degeneration in cortical explants
74. Heart
75. Further enhancement of 3-nitropropanol detoxification by ruminal bacteria in cattle
76. Identification of rumen bacteria that anaerobically degrade aliphatic nitrotoxins
77. Aliphatic nitrocompounds
78. Toxicity of misertoxin and its aglycone (3-nitropropanol) to rats
79. Absorption of 3-nitropropanol (miserotoxin aglycone) from the compound stomach of cattle
80. Conversion of 3-nitropropanol to 3-nitropropionic acid by equine alcohol dehydrogenase
81. Moldy sugar cane poisoning- a case report with a brief review
82. Metabolism of the toxic principle of Astragalus miser var. serotinus in ruminants and nonruminents
83. A method for the detection of beta-nitropropionic acid in crude biological extracts
84. Quantitative determination of 3-nitropropionic acid and 3-nitropropanol in plasma by HPLC
85. Chemical testing with a CHO/HGPRT suspension culture mutation assay
86. The striatum is the most vulnerable region in the brain to mitochondrial energy compromise: a hypothesis to explain its specific vulnerability
87. Acute 3-nitropropionic acid intoxication induces striatal astrocytic cell death and dysfunction of the blood-brain barrier: involvement of dopamine toxicity
88. Estrogen protects against while testosterone exacerbates vulnerability of the lateral striatal artery to chemical hypoxia by 3-nitropropionic acid
89. 3-Nitropropionic acid (3-NPA) produces hypothermia and inhibits histochemical labelling of succinate dehydrogenase (SDH) in rat brain
90. 3-Nitropropionic acid: An astrocyte-sparing neurotoxin in vitro
91. Mycotoxins of Aspergillus oryzae strains used in the food industry as starters and enzyme producing molds
92. Chinese hamster ovary cell assays for mutation and chromosome damage: data from non-carcinogens
93. Major strain differences in response to chronic systemic administration of the mitochondrial toxin 3-nitropropioninc acid in rats: implications for neuroprotection studies
94. Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington's disease
95. Effects of systemic 3-nitropropionic acid-induced lesions of the dorsal striatum on cannabinoid and μ-opioid receptor binding in the basal ganglia
96. Mechanism of cell death induced by the mitochondrial toxin 3-nitropropionic acid: acute excitotoxic necrosis and delayed apoptosis
97. Bioassay of mycotoxins using terrestrial and aquatic, animal and plant species
98. Absorption of 3-nitropropanol and 3-nitroproionic acid from the digestive system of sheep
99. Lack of a protective effect of thiamine on the toxicity of 3-nitropropanol and 3-nitropropionic acid in rats
100. Effect of alcohol and aldehyde dehydrogeanse inhibitors on the toxicty of 3-nitropropanol in rats
101. Evolution of exocrine chemical defense in leaf beetles Coleoptera chrysomelidae
102. Standardized one- and two- dimensional thin layer chromatographic methods for the identification of secondary metabolites in Penicillium and other fungi
103. Toxic effects of mycotoxins in humans
104. 2
105. De novo biosynthesis of DELTA-isoxazolin-5-one and 3-nitropropanoic acid derivativs (defensive secretions in Chrysomela tremulae (c. Tremula)
106. Inhibition of energy metabolism by 3-nitropropionic acid activates ATP-sensitive potassium channels
107. Apoptosis in the striatum of rats following intraperitoneal injection of 3-nitropropionic acid
108. Acute oral toxicity and repellancy of 933 chemicals to house and deer mice
109. Role of ammonium ion in the biosynthesis of beta-nitropropionic acid
110. Biosynthesis of nitro compounds. II. Studies on potential precursors for the nitro group of beta-nitropropionic acid
111. Relationship between beta-nitropropionic acid content of crownvetch and toxicity in nonruminant animals
112. Differential displayed genes in neuroblastoma cells treated with a mitochondrial toxin: evidence for possible involvement of ICAM-1 in 3-nitropropionic acid-mediated neurodegeneration
113. Neurologic diseases associated with use of plant components with toxic potential
114. Miserotoxin, a new naturally occurring nitro compound
115. Increased resistance to chronic oral 3-nitropropionic acid neurotoxicity in aged mice EM and histochemical studies
116. Chronic oral neurotoxcity of 3-nitropropionic acid in mice clinical and neuropathological parallels with murine retroirus-induced spinal cord adaxonal changes
117. Rapid in vitro assay for carcinogenicity of chemical substances in mammalina cells utilizing an attachment-independence endpoint. 2. Assay validation
118. Neurotoxins and neurodegenerative disorders
119. Production of 3-nitropropionic acid by Arthrinium species
120. Toxicological investigations of Astragalus hamosus and Astragalus sesameus
121. Nitro compounds in foreign species of Astragalus
122. Toxic nitro compounds in Lotus
123. Nitro compounds in introduced Astragalus species
124. Toxic nitro compounds in species of Astragalus fabaceae in Argentina
125. Poisoning in sheep from Emory milk vetch and nitro compounds
126. Structure-activity relationships in the rat hepatocyte DNA-Repair test for 300 chemicals
127. 3-Nitropropionic acid toxicity in the striatum
128. Selection of low toxin crownvetch by irradiation
129. Relative vulnerability of dopamine and GABA neurons in mesencephatic cultures to inhibition of succinate dehydrogenase by malonate and 3-nitropropionic acid and protection by NMDA receptor blockade
130. Carcinogenicity of mutgens: predictive capability of the salmonella mutagenesis assay for rodent carcinogenicity